ZYPATT- pancreatic enzyme concentrate tablet 
Patterson Veterinary

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

ZyPatt

Each tablet contains a minimum of:

Lipase..............................9,000 USP units

Protease.........................57,000 USP units

Amylase..........................64,000 USP units

Description:

ZyPatt is a pancreatic enzyme concentrate of porcine origin.

Precautions:

Discontinue use in animals with symptoms of sensitivity or allergy.

FOR ANIMAL USE ONLY

Manufactured by:

Neogen Corporation,

Lexington, KY 40511

Manufactured for:

Patterson Veterinary,

137 Barnum Rd.,

Devens, MA 01434

Pattersonvet.com

Made in USA

KEEP OUT OF REACH OF CHILDREN

Indications:

As a digestive aid in replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.

Directions for use:

Dose is administered before each meal. Estimate dose according to the severity of the condition and weight of the animal.

Average dose/meal:

Dogs: 2-3 tablets

Cats: 1/2-1 tablet

Store tightly closed container in a dry place at a temperature not exceeding 35°C (95°F).

Lot No.:

Exp. Date:

100ct Bottle

NDC #14043-401-85

PATTERSON®

VETERINARY

ZyPatt

TABLETS

PANCREATIC ENZYME CONCENTRATE

CAUTION: Federal law restrics this drug to use by or on the order of a licensed veterinarian.

Net Contents:

100 Tablets

PV196NEO Rev. 04/18

ZyPatt Tablets 100ct

500ct Bottle

NDC #14043-401-89

PATTERSON®

VETERINARY

ZyPatt

TABLETS

PANCREATIC ENZYME CONCENTRATE

CAUTION: Federal law restrics this drug to use by or on the order of a licensed veterinarian.

Net Contents:

500 Tablets

PV197NEO Rev. 04/18

ZyPatt Tablets 500ct

ZYPATT 
pancreatic enzyme concentrate tablet
Product Information
Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:14043-401
Route of AdministrationOral
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PANCRELIPASE LIPASE (UNII: 8MYC33932O) (PANCRELIPASE LIPASE - UNII:8MYC33932O) PANCRELIPASE LIPASE9000 [iU]  in .517 g
PANCRELIPASE AMYLASE (UNII: YOJ58O116E) (PANCRELIPASE AMYLASE - UNII:YOJ58O116E) PANCRELIPASE AMYLASE64000 [iU]  in .517 g
PANCRELIPASE PROTEASE (UNII: 3560D81V50) (PANCRELIPASE PROTEASE - UNII:3560D81V50) PANCRELIPASE PROTEASE57000 [iU]  in .517 g
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize11mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:14043-401-8551.7 g in 1 BOTTLE, PLASTIC
2NDC:14043-401-89258.5 g in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/31/201801/16/2023
Labeler - Patterson Veterinary (006962500)
Establishment
NameAddressID/FEIBusiness Operations
Neogen Corporation042125879analysis, manufacture, label
Establishment
NameAddressID/FEIBusiness Operations
ALI Pharmaceutical Manufacturing, LLC080861914api manufacture
Establishment
NameAddressID/FEIBusiness Operations
Scientific Protein Laboratories LLC065240319analysis, api manufacture

Revised: 1/2023
 
Patterson Veterinary